We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Martin Marietta Materials
MLM
$33B
| $1.11M | ﹤0.01% |
1,811
| – | – |
|
1852
Sensient Technologies
SXT
$5.53B
| $1.11M | ﹤0.01% |
16,058
-7,423
| -32% | -$481K |
|
1853
Consolidated Water Co
CWCO
$488M
| $1.11M | ﹤0.01% |
+37,878
| New | +$1.16M |
|
1854
Shattuck Labs
STTK
$694M
| $1.11M | ﹤0.01% |
+124,179
| New | +$1.14M |
|
1855
Fastly Inc
FSLY
$3.66B
| $1.11M | ﹤0.01% |
85,513
-848,731
| -91% | -$14.3M |
|
|
OKLO
1856
Oklo
OKLO
$8.42B
| $1.11M | ﹤0.01% |
97,000
| – | – |
|
1857
Invesco NASDAQ Internet ETF
PNQI
$541M
| $1.1M | ﹤0.01% |
+27,700
| New | +$1.06M |
|
1858
Applied Industrial Technologies
AIT
$13.3B
| $1.1M | ﹤0.01% |
5,572
+3,300
| +145% | +$603K |
|
1859
Adtran
ADTN
$616M
| $1.1M | ﹤0.01% |
202,076
+139,113
| +221% | +$887K |
|
1860
NorthWestern Energy
NWE
$4.43B
| $1.1M | ﹤0.01% |
+21,565
| New | +$1.05M |
|
1861
Unifirst Corp
UNF
$5.25B
| $1.1M | ﹤0.01% |
6,330
+5,020
| +383% | +$852K |
|
1862
Smith Douglas Homes
SDHC
$116M
| $1.1M | ﹤0.01% |
+36,922
| New | +$1.04M |
|
|
TDAY
1863
USA Today Co
TDAY
$1.06B
| $1.09M | ﹤0.01% |
447,924
-292,043
| -39% | -$656K |
|
1864
Verizon
VZ
$196B
| $1.09M | ﹤0.01% |
26,026
+26
| +0.1% | +$1.05K |
|
|
ITOS
1865
DELISTED
iTeos Therapeutics
ITOS
| $1.09M | ﹤0.01% |
80,052
+52,835
| +194% | +$576K |
|
1866
Myers Industries
MYE
$1.29B
| $1.09M | ﹤0.01% |
47,069
-39,348
| -46% | -$778K |
|
|
NXRT
1867
NexPoint Residential Trust
NXRT
$652M
| $1.09M | ﹤0.01% |
+33,859
| New | +$1.05M |
|
1868
WesBanco
WSBC
$4B
| $1.09M | ﹤0.01% |
36,537
+29,337
| +407% | +$857K |
|
1869
Trip.com Group
TCOM
$29.1B
| $1.09M | ﹤0.01% |
24,807
-25,500
| -51% | -$1.04M |
|
|
FFWM
1870
DELISTED
First Foundation Inc
FFWM
| $1.09M | ﹤0.01% |
144,079
+26,384
| +22% | +$226K |
|
1871
Coastal Financial
CCB
$693M
| $1.09M | ﹤0.01% |
27,944
+2,234
| +9% | +$88.4K |
|
1872
Olema Pharmaceuticals
OLMA
$1.05B
| $1.08M | ﹤0.01% |
95,814
-69,895
| -42% | -$902K |
|
1873
Advanced Energy
AEIS
$13B
| $1.08M | ﹤0.01% |
+10,628
| New | +$1.08M |
|
1874
Artisan Partners
APAM
$3.02B
| $1.08M | ﹤0.01% |
23,680
-28,472
| -55% | -$1.22M |
|
|
HAYN
1875
DELISTED
Haynes International, Inc.
HAYN
| $1.08M | ﹤0.01% |
18,021
-3,678
| -17% | -$212K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.